Navigating Pharma’s Evolving CMO Landscape: An Exclusive Interview with Philip Coetzee, Director of CMO Management, Daiichi Sankyo

This exclusive interview with Philip Coetzee, Director of CMO Management at Daiichi Sankyo, provides a strategic look at the contract manufacturing landscape ahead of the Pharma Contract Manufacturing Summit 2025. With the market facing major shifts due to acquisitions and divestitures, Philip Coetzee shares his perspective on:

• Industry Consolidation: Understand how recent high-profile acquisitions and divestitures are reshaping choices for pharma companies in the CMO market.
• Opportunities for Independent CMOs: Explore how independent CMOs can leverage new collaborative platforms to offer specialised services and gain market share.
• Navigating Market Uncertainty: Learn how pharma companies can address partnership challenges with CMOs in a consolidating market.
• Emerging Trends: Gain insights into the future of contract manufacturing, including the role of niche service providers in a rapidly evolving ecosystem.

Whether you’re a pharma executive, CMO leader, or industry consultant, this interview offers valuable takeaways on navigating industry consolidation, balancing flexibility with control, and identifying growth opportunities in the evolving contract manufacturing landscape.